Edentree Asset Management »

AstraZeneca shares owned by Edentree Asset Management

Quarter-by-quarter ownership of AstraZeneca shares owned by Edentree Asset Management from 13F filings

Historical chart of Edentree Asset Management investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Edentree Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Edentree Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $23M 117k 193.72

More positions owned by Edentree Asset Management

Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Astrazeneca Sponsored Adr
Medtronic SHS (MDT)
Xylem (XYL)
Analog Devices (ADI)
Hannon Armstrong (HASI)
Boston Scientific Corporation (BSX)
Waste Connections (WCN)
Nike CL B (NKE)
Principal Financial (PFG)
Palo Alto Networks (PANW)
Msa Safety Inc equity (MSA)
Broadcom (AVGO)
Advanced Drain Sys Inc Del (WMS)

View all positions for Edentree Asset Management

Top funds holding AstraZeneca

Wellington Management Company
FMR
Sanders Capital
Atlantic Trust
Arrowstreet Capital, Limited Partnership
Neuberger Berman Group
Northern Trust
Raymond James Financial
Fayez Sarofim & Co
American Century Companies
Barclays
Susquehanna International
National Bank Of Canada /fi/
Crawford Investment Counsel
Clark Capital Management Group

View all funds holding AstraZeneca